Koers Amarillo Biosciences, Inc. Other OTC
Aandelen
AMAR
US02301P2056
Biotechnologie & Medisch Onderzoek
Omzet 2022 | 3,52 mln. 3,27 mln. | Omzet 2023 | 122K 114K | Marktkapitalisatie | 8,32 mln. 7,74 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -14 mln. -13,03 mln. | Nettowinst (verlies) 2023 | -13 mln. -12,1 mln. | EV/omzet 2022 | 3,36 x |
Nettoliquiditeiten 2022 | 585K 544K | Nettoschuld 2023 | 3,81 mln. 3,54 mln. | EV/omzet 2023 | 99,3 x |
K/w-verhouding 2022 |
-0,6
x | K/w-verhouding 2023 |
-0,61
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 45,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chun Hsien Tsai
CEO | Chief Executive Officer | 54 | 15-04-21 |
Lawrence Lin
COO | Chief Operating Officer | 55 | 01-08-21 |
Shu Ying Pan
SAM | Sales & Marketing | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yao Chung Chiang
BRD | Director/Board Member | 70 | 15-04-21 |
Pao Sheng Wei
BRD | Director/Board Member | 66 | 15-06-22 |
Chung Yi Tsai
BRD | Director/Board Member | 47 | 15-04-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,65% | 103 mld. | |
+6,75% | 101 mld. | |
+6,40% | 23,07 mld. | |
-12,60% | 22,23 mld. | |
-5,24% | 18,05 mld. | |
-39,98% | 17,18 mld. | |
-10,17% | 16,94 mld. | |
+6,12% | 14,07 mld. | |
+35,47% | 12,35 mld. |